Related Experiment Video
Updated: Jul 3, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
High throughput functional screening of an ion channel library for drug safety and efficacy
1ChanTest Corporation, 14656 Neo Parkway, Cleveland, OH 44128, USA. abrown@chantest.com
Abstract:
Development of a large, representative library of ion channel-expressing cell lines is described. Validation on a full range of automated patch clamp and fluorescence illumination platforms is ongoing. Library "books" can be mixed and matched into channel panels according to tissue, therapeutic area and ion channel family. Unexpected results using a cardiac channel panel show that this panel may serve as a biomarker for cardiac risk assessment.
Insights
A new library of ion channel cell lines was developed. Unexpected findings from a cardiac channel panel suggest its potential as a biomarker for cardiac risk assessment.
Area of Science:
- Pharmacology
- Cell Biology
- Biomarkers
Background:
- Ion channels are crucial drug targets.
- Developing diverse cell line models is essential for drug discovery.
- Current cell line libraries may lack comprehensive coverage.
Purpose of the Study:
- To create a large, representative library of ion channel-expressing cell lines.
- To validate these cell lines on high-throughput screening platforms.
- To explore the utility of custom channel panels for research and diagnostics.
Main Methods:
- Construction of a comprehensive ion channel cell line library.
- Validation using automated patch clamp and fluorescence illumination.
- Formation of tissue- and disease-specific ion channel panels.
Main Results:
- A robust library of ion channel cell lines has been established.
- Validation across multiple platforms is in progress.
- A cardiac channel panel yielded unexpected results, indicating potential as a cardiac risk biomarker.
Conclusions:
- The developed cell line library offers a versatile resource for ion channel research.
- The cardiac channel panel shows promise for cardiac risk assessment.
- Further validation is needed to confirm the biomarker potential.

